PE20040080A1 - Combinaciones de epinastina, belladona y pseudoefefrina como nuevas formulaciones farmaceuticas - Google Patents

Combinaciones de epinastina, belladona y pseudoefefrina como nuevas formulaciones farmaceuticas

Info

Publication number
PE20040080A1
PE20040080A1 PE2003000332A PE2003000332A PE20040080A1 PE 20040080 A1 PE20040080 A1 PE 20040080A1 PE 2003000332 A PE2003000332 A PE 2003000332A PE 2003000332 A PE2003000332 A PE 2003000332A PE 20040080 A1 PE20040080 A1 PE 20040080A1
Authority
PE
Peru
Prior art keywords
belladone
epinastin
pseudoefhrin
combinations
pharmaceutical formulations
Prior art date
Application number
PE2003000332A
Other languages
English (en)
Spanish (es)
Inventor
Noritaka Seko
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20040080A1 publication Critical patent/PE20040080A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE2003000332A 2002-04-03 2003-04-01 Combinaciones de epinastina, belladona y pseudoefefrina como nuevas formulaciones farmaceuticas PE20040080A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007568A EP1350512A1 (en) 2002-04-03 2002-04-03 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations

Publications (1)

Publication Number Publication Date
PE20040080A1 true PE20040080A1 (es) 2004-04-22

Family

ID=27838061

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000332A PE20040080A1 (es) 2002-04-03 2003-04-01 Combinaciones de epinastina, belladona y pseudoefefrina como nuevas formulaciones farmaceuticas

Country Status (12)

Country Link
US (1) US20030228359A1 (cg-RX-API-DMAC7.html)
EP (2) EP1350512A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005522467A (cg-RX-API-DMAC7.html)
AR (1) AR039221A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003221532A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308982A (cg-RX-API-DMAC7.html)
CA (1) CA2477751A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04009582A (cg-RX-API-DMAC7.html)
PE (1) PE20040080A1 (cg-RX-API-DMAC7.html)
PL (1) PL371382A1 (cg-RX-API-DMAC7.html)
RU (1) RU2004132205A (cg-RX-API-DMAC7.html)
WO (1) WO2003082285A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
JP2007517766A (ja) * 2003-09-24 2007-07-05 コンビナトアールエックス インコーポレーティッド 薬物の組み合わせを投与するための治療法
AU2005210086A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
JP4936420B2 (ja) * 2005-08-02 2012-05-23 塩野義製薬株式会社 徐放性顆粒剤
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
RU2366446C1 (ru) * 2008-06-27 2009-09-10 Сергей Анатольевич Небера Гомеопатическое средство для лечения конъюнктивитов
WO2010030418A1 (en) * 2008-09-10 2010-03-18 Micro-Dose Life Sciences Llc Anti-fever botanical composition and uses thereof
RU2567032C2 (ru) * 2009-05-01 2015-10-27 Апталис Фарматек, Инк. Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков
JP5852816B2 (ja) * 2010-09-10 2016-02-03 ロート製薬株式会社 液状医薬組成物、及びこれを含有する軟カプセル剤
RU2478377C1 (ru) * 2011-08-08 2013-04-10 Алексей Владимирович Брынцалов Комбинированный препарат орвиум для устранения симптомов простудных заболеваний и гриппа
CN110237079B (zh) * 2019-07-01 2021-05-14 山西大学 一种百部生物碱类似物的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
AR039221A1 (es) 2005-02-09
EP1350512A1 (en) 2003-10-08
CA2477751A1 (en) 2003-10-09
PL371382A1 (en) 2005-06-13
AU2003221532A1 (en) 2003-10-13
MXPA04009582A (es) 2005-01-11
RU2004132205A (ru) 2005-09-10
US20030228359A1 (en) 2003-12-11
WO2003082285A1 (en) 2003-10-09
BR0308982A (pt) 2005-01-04
JP2005522467A (ja) 2005-07-28
EP1492532A1 (en) 2005-01-05

Similar Documents

Publication Publication Date Title
IS2455B (is) Meðferðarsamsetningar úr blóðþrýstingslækkandi efnum og efnum sem hamla æðamyndun
UY30442A1 (es) Composiciones farmaccuticas de ropinirol, mctodos de uso, proceso de preparacinn y aplicaciones.
AR002355A1 (es) Composiciones y metodos para administracion local de agentes farmaceuticamente activos.
IT1245891B (it) Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
AR032152A1 (es) Uso de una combinacion de compuestos terapeuticos organicos para la fabricacion de un medicamento, un agente terapeutico, y una composicion farmaceutica
AR039336A1 (es) Sistemas analgesicos transdermicos con potencial de abuso reducido
WO2002013801A3 (en) Method of treating the syndrome of coronary heart disease risk factors in humans
JP2007536311A5 (cg-RX-API-DMAC7.html)
AR041089A1 (es) Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
AR068947A1 (es) Inhibidor de la proteina activadora de la 5- lipoxigenasa (flap), composiciones farmaceuticas, sales y solvatos
ATE519486T1 (de) Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
AR039221A1 (es) Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
CO5271717A1 (es) Combinaciones farmaceuticas
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen
AR038141A1 (es) Composiciones farmaceuticas estables que comprenden inhibidor(es) de ace
Desager et al. Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines
AR042543A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides
AR087240A2 (es) Composiciones farmaceuticas que tienen epinastina y pseudoefedrina
AR030095A1 (es) Composicion farmaceutica que contiene citalopram
PY0117547A (es) Composicion de eletriptan en forma de particulas.
EA200702648A1 (ru) Фармацевтическая композиция, пригодная для введения один раз в день
AR044774A1 (es) Composiciones farmaceuticas de atorvastatina
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron

Legal Events

Date Code Title Description
FD Application declared void or lapsed